<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Telomerase is a ribonucleoprotein complex which, by de novo synthesized telomeric TTAGGG repeats, prevents telomere <z:mpath ids='MPATH_580'>erosion</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>While telomerase is active in most <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, conflicting results exist for <z:mpath ids='MPATH_458'>normal</z:mpath> tissues and <z:e sem="disease" ids="C0850639" disease_type="Neoplastic Process" abbrv="">premalignant lesions</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>To establish the telomerase status of <z:mpath ids='MPATH_458'>normal</z:mpath> gastrointestinal mucosa and to elucidate whether telomerase up-regulation is an early or late event in <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e>, we determined the telomerase activity of 88 biopsies of <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa from esophagus, stomach, and intestine and compared it with that of 21 samples of <z:e sem="disease" ids="C0850639" disease_type="Neoplastic Process" abbrv="">premalignant lesions</z:e> and 6 <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> using the telomere-repeat amplification protocol assay </plain></SENT>
<SENT sid="3" pm="."><plain>Telomerase was found in <z:hpo ids='HP_0000001'>all</z:hpo> <z:mpath ids='MPATH_458'>normal</z:mpath> tissues, revealing most activity in esophagus (11 samples), followed by intestine (45 samples), and stomach (32 samples) </plain></SENT>
<SENT sid="4" pm="."><plain>In 53% of the stomach samples, enzyme activity could only be demonstrated when telomerase inhibitors were eliminated by a modified telomerase assay </plain></SENT>
<SENT sid="5" pm="."><plain>In the 21 precancerous lesions (5 <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, 3 stomach <z:mpath ids='MPATH_167'>intestinal metaplasias</z:mpath>, and 13 colorectal <z:mpath ids='MPATH_270'>adenomas</z:mpath> of type I/II <z:mpath ids='MPATH_589'>dysplasia</z:mpath>) a similar or even reduced telomerase activity was seen, while the <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> showed high activity </plain></SENT>
<SENT sid="6" pm="."><plain>These data demonstrate that telomerase activity is expressed in <z:hpo ids='HP_0000001'>all</z:hpo> epithelia along the gastrointestinal tract, thus confirming our previous hypothesis that telomerase is constitutively expressed in permanently renewing epithelia </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, activity was not increased in <z:mpath ids='MPATH_481'>preneoplastic lesions</z:mpath>, suggesting that telomerase up-regulation is a late event during <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> of the esophagus, stomach, and intestine </plain></SENT>
</text></document>